Literature DB >> 19424839

Age and hypertrophy related changes in contractile post-rest behavior and action potential properties in isolated rat myocytes.

Jutta Weisser-Thomas1, Quan Nguyen, Manuela Schuettel, Daniel Thomas, Ulrike Dreiner, Christian Grohé, Rainer Meyer.   

Abstract

"Physiological" aging as well as early and progressive cardiac hypertrophy may affect action potential (AP) pattern, contractile function, and Ca(2+) handling. We hypothesize that contractile function is disturbed in hypertrophy from early stages and is differently affected in aged myocardium. In vivo function, cardiomyocyte contractile behavior and APs were compared in Wistar-Kyoto (WIS) rats and spontaneously hypertensive rats (SHR) at different ages and degrees of hypertrophy (3-4, 9-11, 20-24 months). Post-rest (PR) behavior was used to investigate the relative contribution of the sarcoplasmic reticulum (SR) and the Na/Ca exchanger (NCX) to cytosolic Ca(2+) removal. APs were recorded by whole-cell current-clamp and sarcomere shortening by video microscopy. Cyclopiazonic acid was used to suppress Ca(2+) ATPase (SERCA) function. Heart weight/body weight ratio was increased in SHR versus WIS within all age groups. Myocyte steady state (SS) shortening amplitude was reduced in young SHR versus WIS. Aging led to a significant decay of SS contractile amplitude and relengthening velocity in WIS, but the PR potentiation was maintained. In contrast, aging in SHR led to a decrease of PR potentiation, while SS contraction and relengthening velocity increased. APD(50%) was always prolonged in SHR versus WIS. With aging, APD(50%) increased in both WIS and SHR, but was still shorter in WIS. However, in old WIS the late AP portion (APD(90%)) was prolonged. Ca(2+) handling and AP properties are disturbed progressively with aging and with increasing hypertrophy. Decreased amplitude of shortening and velocity of relengthening in aged WIS may be attributed to reduced SERCA function. In SHR, an increase in SR leak and shift towards transmembraneous Ca handling via NCX may be responsible for the changes in contractile function. A prolonged APD(90%) in aged WIS may be an adaptive mechanism to preserve basal contractility. Therefore, the effects on contractile parameters and AP are different in hypertrophy and aging.

Entities:  

Year:  2007        PMID: 19424839      PMCID: PMC2267030          DOI: 10.1007/s11357-007-9040-1

Source DB:  PubMed          Journal:  Age (Dordr)        ISSN: 0161-9152


  38 in total

Review 1.  Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging.

Authors:  Edward G Lakatta
Journal:  Circulation       Date:  2003-01-28       Impact factor: 29.690

2.  Improved myocardial beta-adrenergic responsiveness and signaling with exercise training in hypertension.

Authors:  Scott M MacDonnell; Hajime Kubo; Deborah L Crabbe; Brian F Renna; Patricia O Reger; Jun Mohara; L Ashley Smithwick; Walter J Koch; Steven R Houser; Joseph R Libonati
Journal:  Circulation       Date:  2005-06-20       Impact factor: 29.690

3.  The cytosolic calcium transient modulates the action potential of rat ventricular myocytes.

Authors:  W H duBell; M R Boyett; H A Spurgeon; A Talo; M D Stern; E G Lakatta
Journal:  J Physiol       Date:  1991-05       Impact factor: 5.182

4.  Reduced myocardial sarcoplasmic reticulum Ca(2+)-ATPase protein expression in compensated primary and secondary human cardiac hypertrophy.

Authors:  U Schotten; B Koenigs; M Rueppel; F Schoendube; P Boknik; W Schmitz; P Hanrath
Journal:  J Mol Cell Cardiol       Date:  1999-08       Impact factor: 5.000

Review 5.  Abnormalities of calcium cycling in the hypertrophied and failing heart.

Authors:  S R Houser; V Piacentino; J Weisser
Journal:  J Mol Cell Cardiol       Date:  2000-09       Impact factor: 5.000

6.  Alterations in properties of L-type Ca channels in aging rat heart.

Authors:  Ira R Josephson; Antonio Guia; Michael D Stern; Edward G Lakatta
Journal:  J Mol Cell Cardiol       Date:  2002-03       Impact factor: 5.000

7.  The role of aging on the control of contractile force by Na(+)-Ca2+ exchange in rat papillary muscle.

Authors:  P Abete; N Ferrara; A Cioppa; P Ferrara; S Bianco; C Calabrese; C Napoli; F Rengo
Journal:  J Gerontol A Biol Sci Med Sci       Date:  1996-09       Impact factor: 6.053

8.  Profile and kinetics of L-type calcium current during the cardiac ventricular action potential compared in guinea-pigs, rats and rabbits.

Authors:  K W Linz; R Meyer
Journal:  Pflugers Arch       Date:  2000-03       Impact factor: 3.657

9.  The spontaneously hypertensive rat as a model of the transition from compensated left ventricular hypertrophy to failure.

Authors:  O H Bing; W W Brooks; K G Robinson; M T Slawsky; J A Hayes; S E Litwin; S Sen; C H Conrad
Journal:  J Mol Cell Cardiol       Date:  1995-01       Impact factor: 5.000

Review 10.  Animal models of human cardiovascular disease, heart failure and hypertrophy.

Authors:  G Hasenfuss
Journal:  Cardiovasc Res       Date:  1998-07       Impact factor: 10.787

View more
  3 in total

Review 1.  Cardiac remodeling and subcellular defects in heart failure due to myocardial infarction and aging.

Authors:  Naranjan S Dhalla; Shashanka Rangi; Andrea P Babick; Shelley Zieroth; Vijayan Elimban
Journal:  Heart Fail Rev       Date:  2012-09       Impact factor: 4.214

2.  Nicorandil stimulates a Na⁺/Ca²⁺ exchanger by activating guanylate cyclase in guinea pig cardiac myocytes.

Authors:  Jiazhang Wei; Yasuhide Watanabe; Kazuhiko Takeuchi; Kanna Yamashita; Miyuki Tashiro; Satomi Kita; Takahiro Iwamoto; Hiroshi Watanabe; Junko Kimura
Journal:  Pflugers Arch       Date:  2015-12-03       Impact factor: 3.657

Review 3.  Modulation of the cardiac sodium/bicarbonate cotransporter by the renin angiotensin aldosterone system: pathophysiological consequences.

Authors:  Verónica C De Giusti; María C Ciancio; Alejandro Orlowski; Ernesto A Aiello
Journal:  Front Physiol       Date:  2014-01-17       Impact factor: 4.566

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.